ACADIA Pharmaceuticals Inc.
ACADIA Pharmaceuticals Inc. (ACAD) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ACAD · as of Jun 8, 2026
Key Statistics
Explore ACADIA Pharmaceuticals Inc. Data
acad stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 37 · Buy rate: 70.3%
The ACAD analyst consensus is Buy, based on ratings from 37 Wall Street analysts over the past 3 months. The average 12-month price target is $34.78, representing +61.32% upside from the current price of $21.56.
Competitors & Peers
acad competitorsACAD
ADMA
BLTE
CRNX
DYN
IMVTStock Performance
Full HistoryAbout ACADIA Pharmaceuticals Inc.
ACADIA Pharmaceuticals Inc. a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders.…
what is acadia pharmaceuticals inc. · acad stock overview · acadia pharmaceuticals inc. company profile · who is acadia pharmaceuticals inc. ceo · acad NASDAQ · acadia pharmaceuticals inc. headquarters · acadia pharmaceuticals inc. business segments
About Stock Overview & Key Data
ACADIA Pharmaceuticals Inc. (ACAD) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since May 27, 2004. As of the latest trading session, ACAD stock price is $21.56, with a market capitalization of $3.7B. The stock has returned -3.32% over the past 12 months and -19.28% year-to-date.
According to 37 Wall Street analysts, the consensus rating for ACADIA Pharmaceuticals Inc. stock is Buy, with an average 12-month price target of $34.78. In fiscal year 2025, ACADIA Pharmaceuticals Inc. reported revenue of $1.1B and net income of $391.0M. For detailed data — including ACADIA Pharmaceuticals Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, ACADIA Pharmaceuticals Inc. (ACAD) stock price is $21.56. The stock is traded on NASDAQ under the ticker symbol ACAD. The 52-week range is $19.69 – $28.35.